LATEST NEWS

Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.
LJI scientists uncover coordinated immune cell activity as a driver of systemic lupus erythematosus
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Dr. Altman’s research into T cell activation opened the door to new therapies for inflammation, autoimmune diseases, cancers, and more.
No one knows exactly what triggers type 1 diabetes, but researchers at La Jolla Institute for Immunology have uncovered some fascinating clues.
San Diego biotech entrepreneurs François Ferré, Ph.D., and Magda Marquet, Ph.D., knew supporting LJI would be critical for advancing our understanding of COVID-19.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
Karen Barnes reflects on a career in science—from tracking elephants to supporting LJI research
New study highlights VP40 as a promising therapeutic target
How Ian Mathews used Tullie and Rickey Families SPARK Awards funding to make cancer therapy advances and launch a career in medicine